{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:41:06Z","timestamp":1771051266436,"version":"3.50.1"},"reference-count":58,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.2967\/jnumed.116.185017","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:20:11Z","timestamp":1503015611000},"page":"1711-1717","source":"Crossref","is-referenced-by-count":94,"title":["Clinical Use and Utility of Amyloid Imaging"],"prefix":"10.2967","volume":"58","author":[{"given":"Henryk","family":"Barthel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"2021051712111583000_58.11.1711.1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"2021051712111583000_58.11.1711.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"2021051712111583000_58.11.1711.3","unstructured":"Public attitudes about diagnosis: value of knowing. Alzheimer Europe website. http:\/\/www.alzheimer-europe.org\/Research\/Value-of-Knowing\/Public-attitudes-about-diagnosis. Updated July 13, 2011. Accessed August 21, 2017."},{"key":"2021051712111583000_58.11.1711.4","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181a6bebc"},{"key":"2021051712111583000_58.11.1711.5","doi-asserted-by":"publisher","DOI":"10.1177\/1533317510394648"},{"key":"2021051712111583000_58.11.1711.6","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e318181e4c7"},{"key":"2021051712111583000_58.11.1711.7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3233\/JAD-2012-121216","article-title":"Dementia specialists and early adoption of amyloid imaging","volume":"33","author":"Klein","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"2021051712111583000_58.11.1711.8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neurobiolaging.2016.07.012","article-title":"Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"52","author":"Chiotis","year":"2017","journal-title":"Neurobiol Aging."},{"key":"2021051712111583000_58.11.1711.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70320-4"},{"key":"2021051712111583000_58.11.1711.10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000439255","article-title":"Do beliefs about the pathogenetic role of amyloid affect the interpretation of amyloid PET in the clinic?","volume":"16","author":"Boccardi","year":"2016","journal-title":"Neurodegener Dis."},{"key":"2021051712111583000_58.11.1711.11","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt93"},{"key":"2021051712111583000_58.11.1711.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.03.014"},{"key":"2021051712111583000_58.11.1711.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.120618"},{"key":"2021051712111583000_58.11.1711.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.127068"},{"key":"2021051712111583000_58.11.1711.15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000441139","article-title":"Effect of amyloid imaging on the diagnosis and management of patients with cognitive decline: impact of appropriate use criteria","volume":"41","author":"Grundman","year":"2016","journal-title":"Dement Geriatr Cogn Disord."},{"key":"2021051712111583000_58.11.1711.16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dadm.2016.12.001","article-title":"Critical review of the appropriate use criteria for amyloid imaging: effect on diagnosis and patient care","volume":"5","author":"Apostolova","year":"2016","journal-title":"Alzheimers Dement (Amst)."},{"key":"2021051712111583000_58.11.1711.17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-016-0228-4","article-title":"Diagnostic impact of [18F]flutemetamol PET in early-onset dementia","volume":"9","author":"Zwan","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"2021051712111583000_58.11.1711.18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/14737175.2015.1023296","article-title":"The role of positron emission tomography imaging in understanding Alzheimer\u2019s disease","volume":"15","author":"Barthel","year":"2015","journal-title":"Expert Rev Neurother."},{"key":"2021051712111583000_58.11.1711.19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","article-title":"Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol \u03b2-amyloid PET brain images","volume":"38","author":"Buckley","year":"2017","journal-title":"Nucl Med Commun."},{"key":"2021051712111583000_58.11.1711.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161927"},{"key":"2021051712111583000_58.11.1711.21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00259-016-3601-4","article-title":"Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging","volume":"44","author":"Pontecorvo","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712111583000_58.11.1711.22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00259-017-3644-1","article-title":"Yes we can analyse amyloid images: now what?","volume":"44","author":"Barthel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712111583000_58.11.1711.23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/13607860120080297","article-title":"Should a diagnosis of Alzheimer\u2019s disease be disclosed?","volume":"5","author":"Sullivan","year":"2001","journal-title":"Aging Ment Health."},{"key":"2021051712111583000_58.11.1711.24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/nmt.13.25","article-title":"Amyloid imaging, risk disclosure and Alzheimer\u2019s disease: ethical and practical issues","volume":"3","author":"Roberts","year":"2013","journal-title":"Neurodegener Dis Manag."},{"key":"2021051712111583000_58.11.1711.25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt206","article-title":"Would you want to know? Public attitudes on early diagnostic testing for Alzheimer\u2019s disease","volume":"5","author":"Wikler","year":"2013","journal-title":"Alzheimers Res Ther."},{"key":"2021051712111583000_58.11.1711.26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1017\/S1041610214000969","article-title":"Preferences regarding disclosure of a diagnosis of dementia: a systematic review","volume":"26","author":"van den Dungen","year":"2014","journal-title":"Int Psychogeriatr."},{"key":"2021051712111583000_58.11.1711.27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/WNL.0b013e3182a55f4a","article-title":"Using AD biomarker research results for clinical care: a survey of ADNI investigators","volume":"81","author":"Shulman","year":"2013","journal-title":"Neurology."},{"key":"2021051712111583000_58.11.1711.28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/13506129.2014.926267","article-title":"Use of amyloid PET across the spectrum of Alzheimer\u2019s disease: clinical utility and associated ethical issues","volume":"21","author":"Leuzy","year":"2014","journal-title":"Amyloid."},{"key":"2021051712111583000_58.11.1711.29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-017-0261-y","article-title":"Communicating mild cognitive impairment diagnoses with and without amyloid imaging","volume":"9","author":"Grill","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"2021051712111583000_58.11.1711.30","doi-asserted-by":"crossref","first-page":"741.e2","DOI":"10.1016\/j.jalz.2012.09.014","article-title":"Disclosure of amyloid imaging results to research participants: has the time come?","volume":"9","author":"Lingler","year":"2013","journal-title":"Alzheimers Dement."},{"key":"2021051712111583000_58.11.1711.31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-150985","article-title":"Development of a standardized approach to disclosing amyloid imaging research results in mild cognitive impairment","volume":"52","author":"Lingler","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"2021051712111583000_58.11.1711.32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2015.09.005","article-title":"Disclosure of positron emission tomography amyloid imaging results: a preliminary study of safety and tolerability","volume":"12","author":"Lim","year":"2016","journal-title":"Alzheimers Dement."},{"key":"2021051712111583000_58.11.1711.33","doi-asserted-by":"crossref","unstructured":"Burns JM Johnson DK Liebmann EP Bothwell RJ Morris JK Vidoni ED . Safety of disclosing amyloid status in cognitively normal older adults. Alzheimers Dement. March 3, 2017 [Epub ahead of print].","DOI":"10.1016\/j.jalz.2017.01.022"},{"key":"2021051712111583000_58.11.1711.34","doi-asserted-by":"publisher","DOI":"10.1159\/000345783"},{"key":"2021051712111583000_58.11.1711.35","doi-asserted-by":"publisher","DOI":"10.1159\/000339367"},{"key":"2021051712111583000_58.11.1711.36","doi-asserted-by":"crossref","unstructured":"Guo S Getsios D Hernandez L . Florbetaben PET in the early diagnosis of Alzheimer's disease: a discrete event simulation to explore its potential value and key data gaps. Int J Alzheimers Dis. 2012:548157.","DOI":"10.1155\/2012\/548157"},{"key":"2021051712111583000_58.11.1711.37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000356273","article-title":"Re-evaluation of clinical dementia diagnoses with Pittsburgh compound B positron emission tomography","volume":"3","author":"Degerman Gunnarsson","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra."},{"key":"2021051712111583000_58.11.1711.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.07.003"},{"key":"2021051712111583000_58.11.1711.39","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e318279d02a"},{"key":"2021051712111583000_58.11.1711.40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-9-10","article-title":"A consecutive case series experience with [18F]florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition","volume":"9","author":"Mitsis","year":"2014","journal-title":"Mol Neurodegener."},{"key":"2021051712111583000_58.11.1711.41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000032"},{"key":"2021051712111583000_58.11.1711.42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/13554794.2013.791867","article-title":"Impact of 18F-florbetapir PET imaging of \u03b2-amyloid neuritic plaque density on clinical decision-making","volume":"20","author":"Zannas","year":"2014","journal-title":"Neurocase."},{"key":"2021051712111583000_58.11.1711.43","first-page":"63","article-title":"Cost-effectiveness of florbetapir-PET in Alzheimer\u2019s disease: a Spanish societal perspective","volume":"18","author":"Hornberger","year":"2015","journal-title":"J Ment Health Policy Econ."},{"key":"2021051712111583000_58.11.1711.44","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaneurol.2016.3751","article-title":"Assessment of the incremental diagnostic value of florbetapir F18 imaging in patients with cognitive impairment: the Incremental Diagnostic Value of Amyloid PET with [18F]-Florbetapir (INDIA-FBP) Study","volume":"73","author":"Boccardi","year":"2016","journal-title":"JAMA Neurol."},{"key":"2021051712111583000_58.11.1711.45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3233\/JAD-151180","article-title":"Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers","volume":"52","author":"Bensa\u00efdane","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"2021051712111583000_58.11.1711.46","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3233\/JAD-160302","article-title":"Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid?","volume":"54","author":"Weston","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"2021051712111583000_58.11.1711.47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00115-016-0249-z","article-title":"Amyloid positron-emission-tomography with [18F]-florbetaben in the diagnostic workup of dementia patients","volume":"88","author":"Sch\u00f6necker","year":"2017","journal-title":"Nervenarzt."},{"key":"2021051712111583000_58.11.1711.48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/03007995.2016.1277197","article-title":"Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer\u2019s disease: the case of florbetapir","volume":"33","author":"Hornberger","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"2021051712111583000_58.11.1711.49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/cjn.2015.401","article-title":"Canadian consensus guidelines on use of amyloid imaging in Canada: update and future directions from the specialized task force on amyloid imaging in Canada","volume":"43","author":"Laforce","year":"2016","journal-title":"Can J Neurol Sci."},{"key":"2021051712111583000_58.11.1711.50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/WAD.0000000000000168","article-title":"The potential value of \u03b2-amyloid imaging for the diagnosis and management of dementia: a survey of clinicians","volume":"31","author":"Zhong","year":"2017","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"2021051712111583000_58.11.1711.51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/nmt-2016-0059","article-title":"The impact of \u03b2-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia experts","volume":"7","author":"Ganz","year":"2017","journal-title":"Neurodegener Dis Manag."},{"key":"2021051712111583000_58.11.1711.52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.dadm.2015.06.006","article-title":"Clinical use of amyloid-positron emission tomography neuroimaging: practical and bioethical considerations","volume":"1","author":"Witte","year":"2015","journal-title":"Alzheimers Dement (Amst)."},{"key":"2021051712111583000_58.11.1711.53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamainternmed.2013.11705","article-title":"The Centers for Medicare & Medicaid Services and amyloid-\u03b2 positron emission tomography for Alzheimer disease","volume":"174","author":"Steinbrook","year":"2014","journal-title":"JAMA Intern Med."},{"key":"2021051712111583000_58.11.1711.54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3333"},{"key":"2021051712111583000_58.11.1711.55","unstructured":"Home page. iDEAS website. www.ideas-study.org. Accessed August 21, 2017."},{"key":"2021051712111583000_58.11.1711.56","unstructured":"Home page. AMYPAD website. www.amypad.eu. Accessed August 21, 2017."},{"key":"2021051712111583000_58.11.1711.57","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","article-title":"Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection","volume":"14","author":"Teipel","year":"2015","journal-title":"Lancet Neurol."},{"key":"2021051712111583000_58.11.1711.58","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00259-016-3462-x","article-title":"Feasibility and acceptance of simultaneous amyloid PET\/MRI","volume":"43","author":"Sch\u00fctz","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.116.185017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:19:11Z","timestamp":1621282751000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.116.185017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.2967\/jnumed.116.185017"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.116.185017","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}